Parallel Industries

Parallel Industries Equity Ratio

The Equity Ratio of Parallel Industries (EAPH) as of Nov 19, 2026 is 67.78 %. In the previous year, Equity Ratio was 41.33 % — a change of 64.01% (higher).

Equity Ratio

67.78 %

YoY

64.01%

Last updated:

Equity Ratio of Parallel Industries is 2020 67.78 % . Equity Ratio of Parallel Industries was 2019 41.33 % . It decreases by 64.01% higher compared to the previous year.

The Parallel Industries Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2014
89.00 USD
Jan 1, 2015
88.91 USD
Jan 1, 2016
38.31 USD
Jan 1, 2017
6.10 USD
Jan 1, 2018
70.30 USD
Jan 1, 2019
41.33 USD
Jan 1, 2020
67.78 USD
The Parallel Industries Equity Ratio history
YEAREquity RatioYoY
67.78 %+64.01%
41.33 %-41.21%
70.30 %+1,053.45%
6.10 %-84.09%
38.31 %-56.92%
88.91 %-0.09%
89.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parallel Industries Stock analysis

What does Parallel Industries do? Easton Pharmaceuticals Inc. is a Canada-based company specializing in the healthcare sector and alternative medicines. It was founded in 1997 and has been listed on the Canadian Securities Exchange since 2014. The company distributes its products in the United States, Canada, Mexico, Europe, and Asia, offering a wide range of products and services including medications, medical devices, cosmetics, supplements, and agricultural products. It operates in various sectors such as the pharmaceutical industry, cosmetics industry, agricultural industry, and medical devices industry. The main business areas of the company are pharmaceuticals and cosmetic products, offering medications for neuropathic pain, chronic fatigue pain, arthritis, as well as cosmetic products with organic ingredients tailored to specific skin needs. Easton Pharmaceuticals also has a presence in the agricultural market, providing fertilizers and pesticides to promote plant growth and increase crop yields. Additionally, the company offers medical devices such as wound dressings, splints, and bandages for injury treatment. It has also invested in real estate for the development of large shopping centers and hotels. The company's business model focuses on providing products and services specifically tailored to the needs of individuals preferring alternative medicines and beauty products. Easton Pharmaceuticals continually strives to expand its brands and introduce new products to the market, while collaborating with other companies to find innovative solutions to medical and health-related problems. In 2020, Easton Pharmaceuticals entered the cannabis sector by signing an agreement with a Canadian company for hemp seed production and marketing. Overall, Easton Pharmaceuticals is a multi-sector company aiming to offer products and services tailored to specific individuals' needs, with a reputation in the industry and a commitment to expanding its presence in the future. Parallel Industries is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parallel Industries stock

Equity Ratio of Parallel Industries is 67.78 % in 2020.

Equity Ratio of Parallel Industries changed from 41.33 % to 67.78 %, representing a 64.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Parallel Industries since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Parallel Industries with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Parallel Industries

All Key Metrics — Parallel Industries